The Visibility Gap

Every AI answer cites its sources. Are you one of them?

When a healthcare professional, journalist, or decision-maker asks an AI assistant about your therapeutic area, the answer arrives with citations — and your competitor may be in them, not you. Search engines rank pages. LLMs choose sources. In GEOMed360 field audits of a launch-phase oncology therapy, manufacturer-owned pages captured under 10 percent of AI citations — and gated portal content captured exactly zero. Winning the answer means being chosen, and most pharma companies haven't entered the competition yet.

Definition

What is Generative Engine Optimization?

Generative Engine Optimization (GEO) is the discipline of structuring your content, data, and digital presence so that large language models accurately surface, cite, and represent your organisation when generating responses. The term was formalized in a 2024 peer-reviewed study (KDD 2024), which showed that specific content interventions raise visibility in AI answers by up to 40 percent.

GEO · Generative Engine Optimization

The practice of optimizing digital assets — content, structure, metadata, and authority signals — so they are accurately cited by AI systems such as ChatGPT, Claude, Gemini, and Perplexity when answering questions in your domain. In pharma, this means ensuring your scientific evidence, therapeutic expertise, and product information is what AI systems draw upon. Read the deep dive in Chapter 3: Inside the machine.

GEO vs. SEO

The click was the prize. Now it's the answer.

Comparison of traditional SEO and Generative Engine Optimization
DimensionTraditional SEOGEO
You're winning…The clickThe answer
Target systemSearch engine crawlerLarge language model
OutcomeRanked link on results pageCited source in AI answer
Key signalsBacklinks, keywords, speedEntity clarity, structure, authority
Pharma riskRegulatory copy constraintsMisinformation in AI responses
AI discovery filerobots.txtllms.txt
The Research

Winning the answer: the whitepaper, published in full

No form. No download gate. The complete GEOMed360 whitepaper — evidence base, multi-model field audits, the operating framework, and the blueprint for building a GEO capability in-house — is published openly across this site, structured exactly the way GEO best practice says evidence should be published. Start at the executive summary or jump into a chapter.

CHAPTER 01 The great rewiring of health information discovery How AI answers replaced ranked links in health information: click-through collapse, physician and patient adoption of AI assistants, and what it means for pharma digital strategy. CHAPTER 02 Why pharmaceutical companies are uniquely exposed Four structural features that make pharma's exposure to AI-mediated information qualitatively different: regulatory asymmetry, dual audiences, machine-hostile legacy content, and hallucination risk. CHAPTER 03 Inside the machine: how generative engines select evidence The three technical layers behind AI answers — LLMs, semantic search, and retrieval-augmented generation — and the peer-reviewed evidence on which GEO tactics actually move AI visibility. CHAPTER 04 Field evidence: what multi-model audits actually reveal Five findings from GEOMed360's multi-model, dual-persona audit programme across oncology, cardiometabolic and interstitial lung disease assets: citation mix, format effects, systematic errors, persona gaps, and model heterogeneity. CHAPTER 05 The GEO operating framework A GEO operating framework for pharma: the three-tier content architecture, lifecycle sequencing from clinical development to post-launch, and the PICO standard for machine-readable claims. CHAPTER 06 Standing up the capability in-house How pharmaceutical companies build an internal GEO capability: the build-and-transfer principle, pilot sequencing, cross-functional governance, the three-phase service workflow, ownership matrix, and compliance-aware operating rules.

Read the full whitepaper →

How We Work

Ad-hoc, tailored, and always alongside your team

No standard packages. Every engagement is shaped around your organisation's starting point, your therapeutic priorities, and your team's pace — from a first conversation about GEO to an ongoing embedded partnership. We accompany you through this, not just hand over deliverables. Our end state is yours: a standing in-house capability, exactly as set out in Chapter 6 of our research.

Education & Activation

GEO Foundations

An intensive, tailored session — half-day or full-day — designed to build GEO understanding from within your team. We work directly with you, aligning to your therapeutic areas, your audience, and your digital maturity, so the knowledge lands, sticks, and becomes actionable.

  • What GEO is and how it differs from SEO
  • How LLMs surface pharmaceutical and clinical information
  • Live demos using your own therapeutic area queries
  • Regulatory and compliance dimensions of GEO
  • Practical first steps your team can own immediately
Embedded Partnership

GEO Partnership

An ongoing engagement where GEOMed360 works alongside your team — joining planning cycles, reviewing content, guiding implementation, and iterating as the AI landscape evolves. We install the capability, run the first cycles jointly, and transfer every asset — so it stays in-house.

  • Multi-model, dual-persona AI-visibility audit
  • Prompt libraries and ideal clinical answer matrix
  • Structured data, PICO content standards, LLMs.txt
  • Governance, ownership matrix and compliance rules
  • Citation monitoring, KPI stack and joint iteration
Why GEOMed360

Pharma expertise meets AI fluency

Medical Information Medical Affairs Digital Health Pharma Digital Strategy Generative AI GEO & LLM Optimization

GEOMed360 was built at the convergence of two domains that rarely meet: deep pharmaceutical expertise and hands-on generative AI practice. Most GEO consultancies know digital, but not pharma. Most pharma consultancies know the industry, but not AI. We know both.

With extensive backgrounds in medical information, medical affairs, and pharma digital strategy, we have operated inside the regulatory, scientific, and commercial complexity of life sciences — and our research is built on a multi-model, dual-persona audit programme across oncology, cardiometabolic disease, and interstitial lung disease.

GEOMed360 doesn't parachute in with a framework and leave. We partner with your teams over time, building internal capability as we build your AI visibility — because winning the answer isn't a one-off project. It's a position you earn and hold.

Common Questions

Frequently asked about GEO in pharma

What does "winning the answer" mean?

It's the goal of GEO in one phrase. SEO competed for the click — a ranked position on a results page. GEO competes for the answer itself: when an AI assistant responds to a question in your therapeutic area, winning the answer means your organisation is the source it cites and accurately represents.

What is Generative Engine Optimization (GEO)?

GEO is the practice of optimizing your content and digital presence so large language models — ChatGPT, Claude, Gemini, Perplexity — surface and cite your organisation accurately. The term was formalized in a 2024 peer-reviewed study which showed content interventions can raise AI-answer visibility by up to 40 percent. Read how the engines work →

Why does GEO matter specifically for pharma?

92% of surveyed physicians now use generative AI in clinical practice, and 40M+ Americans ask AI health questions daily — yet in our field audits, manufacturer-owned pages captured under 10% of AI citations for a launch-phase asset. See the field evidence →

Is GEO compatible with pharma regulatory requirements?

GEO is about making accurate, well-structured information more accessible to AI systems — which aligns with ensuring compliant information is what gets cited. Our research includes four compliance-aware operating rules agreed once with MLR, including pre-cleared PICO evidence blocks. Read the rules →

What does "embedded partnership" mean in practice?

It means GEOMed360 joins your planning cycles, attends your reviews, and works through your real content and priorities — installing a standing in-house capability and transferring every asset, rather than delivering a static package and stepping away. The engagement evolves as you do.

How do we start working together?

It starts with a conversation — no forms, no sales process. Reach out by email and we'll take it from there, beginning with understanding your team's situation and where GEO fits your priorities. Every engagement is scoped from scratch.

Ready to win the answer?

GEOMed360 works as your partner — not a vendor. Every collaboration begins with understanding where you are, what your teams need, and how GEO fits your strategic priorities. Reach out and let's start a conversation.

Start a conversation →